Back to top
more

LeMaitre Vascular (LMAT)

(Delayed Data from NSDQ)

$65.46 USD

65.46
117,291

+2.47 (3.92%)

Updated Apr 26, 2024 04:00 PM ET

After-Market: $65.45 -0.01 (-0.02%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

1-Strong Buy of 5 1        

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value C Growth D Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 44% (142 out of 252)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

Research for LMAT

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

0 items in cart

LeMaitre Vascular, Inc. [LMAT]

Reports for Purchase

Showing records 161 - 180 ( 188 total )

Company: LeMaitre Vascular, Inc.

Industry: Medical - Products

Record: 161

04/30/2014

Daily Note

Pages: 3

MORNING SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: LeMaitre Vascular, Inc.

Industry: Medical - Products

Record: 162

04/30/2014

Company Report

Pages: 3

Hit on the Top Line and a Miss on the Bottom- Line--but Things Should Improve Quickly

Provider: The Benchmark Company

Analyst: WALD J

Price: 10.00

Research Provided by a Third Party

Company: LeMaitre Vascular, Inc.

Industry: Medical - Products

Record: 163

04/30/2014

Company Report

Pages: 9

Mixed 1Q but 2014 Still Intact; Cost Initiatives to Drive 2H14 Leverage

Provider: Roth Capital Partners, Inc.

Analyst: LEWIS C

Price: 25.00

Research Provided by a Third Party

Company: LeMaitre Vascular, Inc.

Industry: Medical - Products

Record: 164

04/29/2014

Daily Note

Pages: 3

MORNING SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: LeMaitre Vascular, Inc.

Industry: Medical - Products

Record: 165

04/28/2014

Daily Note

Pages: 5

1Q Preview: Risk-Reward Profile Remains Attractive

Provider: Roth Capital Partners, Inc.

Analyst: LEWIS C

Price: 10.00

Research Provided by a Third Party

Company: LeMaitre Vascular, Inc.

Industry: Medical - Products

Record: 166

04/07/2014

Industry Report

Pages: 8

Healthcare: 1Q 2014: Quarterly Medical Technology Trading & Acquisition Valuation Update

Provider: Roth Capital Partners, Inc.

Analyst: LEWIS C

Price: 25.00

Research Provided by a Third Party

Company: LeMaitre Vascular, Inc.

Industry: Medical - Products

Record: 167

03/07/2014

Industry Report

Pages: 36

Healthcare -2014 Conference - Med Tech "Cheat Sheet"

Provider: Roth Capital Partners, Inc.

Analyst: LEWIS C

Price: 75.00

Research Provided by a Third Party

Company: LeMaitre Vascular, Inc.

Industry: Medical - Products

Record: 168

02/26/2014

Company Report

Pages: 12

Good Growth, Expansion More Than Makes Up for Lower Margins

Provider: The Benchmark Company

Analyst: WALD J

Price: 25.00

Research Provided by a Third Party

Company: LeMaitre Vascular, Inc.

Industry: Medical - Products

Record: 169

02/26/2014

Daily Note

Pages: 6

Morning Call

Provider: The Benchmark Company

Price: 25.00

Research Provided by a Third Party

Company: LeMaitre Vascular, Inc.

Industry: Medical - Products

Record: 170

02/26/2014

Daily Note

Pages: 3

MORNING SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: LeMaitre Vascular, Inc.

Industry: Medical - Products

Record: 171

02/26/2014

Company Report

Pages: 8

Solid 4Q Despite Margin Pressures; 2014 Revenue Guidance Exceeds; Buy

Provider: Roth Capital Partners, Inc.

Analyst: LEWIS C

Price: 25.00

Research Provided by a Third Party

Company: LeMaitre Vascular, Inc.

Industry: Medical - Products

Record: 172

02/25/2014

Daily Note

Pages: 3

MORNING SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: LeMaitre Vascular, Inc.

Industry: Medical - Products

Record: 173

02/24/2014

Daily Note

Pages: 3

MID-DAY SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: LeMaitre Vascular, Inc.

Industry: Medical - Products

Record: 174

02/24/2014

Company Report

Pages: 5

4Q Preview: Expecting Inline 4Q, ''14 Guide; Risk-Reward Remains Attractive

Provider: Roth Capital Partners, Inc.

Analyst: LEWIS C

Price: 10.00

Research Provided by a Third Party

Company: LeMaitre Vascular, Inc.

Industry: Medical - Products

Record: 175

11/15/2013

Daily Note

Pages: 3

MORNING CALL SUMMARY

Provider: Roth Capital Partners, Inc.

Price: 10.00

Research Provided by a Third Party

Company: LeMaitre Vascular, Inc.

Industry: Medical - Products

Record: 176

11/15/2013

Company Report

Pages: 12

Encouraging Analyst Day Takeaways - Reiterate Buy

Provider: Roth Capital Partners, Inc.

Analyst: LEWIS C

Price: 25.00

Research Provided by a Third Party

Company: LeMaitre Vascular, Inc.

Industry: Medical - Products

Record: 177

11/13/2013

Daily Note

Pages: 11

Morning Call

Provider: The Benchmark Company

Price: 25.00

Research Provided by a Third Party

Company: LeMaitre Vascular, Inc.

Industry: Medical - Products

Record: 178

11/13/2013

Company Report

Pages: 11

Analyst Meeting: Sales Force To Drive Growth, Though Company Strengths Run Deep As Well

Provider: The Benchmark Company

Analyst: WALD J

Price: 25.00

Research Provided by a Third Party

Company: LeMaitre Vascular, Inc.

Industry: Medical - Products

Record: 179

11/01/2013

Industry Report

Pages: 6

TCT Meeting Update

Provider: The Benchmark Company

Analyst: WALD J

Price: 25.00

Research Provided by a Third Party

Company: LeMaitre Vascular, Inc.

Industry: Medical - Products

Record: 180

10/30/2013

Company Report

Pages: 11

Strong 12% Revenue Growth in the Quarter and Raising Revenue Guidance; Increasing Price Target to $10

Provider: The Benchmark Company

Analyst: WALD J

Price: 25.00

Research Provided by a Third Party